BE-61-OB65_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide, Angiogenesis Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Inhibitors of Signal Transduction Pathways targeting FLT4, KDR (Novartis, 6398883)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/6398883
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the BE-61-OB65_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GAPDH glyceraldehyde-3-phosphate dehydrogenase 1.24702
FAM110A family with sequence similarity 110, member A 0.719984
OAZ1 ornithine decarboxylase antizyme 1 0.564069
RPS16 ribosomal protein S16 0.564069
RPS18 ribosomal protein S18 0.534836
CHGA chromogranin A 0.416539
GCNA germ cell nuclear acidic peptidase 0.311621
RPS11 ribosomal protein S11 0.309324
TPO thyroid peroxidase 0.247777
RPL18A ribosomal protein L18a 0.247777
UBC ubiquitin C 0.2088